Annual Cash & Cash Equivalents
$96.34 M
+$71.85 M+293.43%
December 31, 2023
Summary
- As of February 12, 2025, SPRB annual cash & cash equivalents is $96.34 million, with the most recent change of +$71.85 million (+293.43%) on December 31, 2023.
- During the last 3 years, SPRB annual cash & cash equivalents has fallen by -$60.81 million (-38.70%).
- SPRB annual cash & cash equivalents is now -38.70% below its all-time high of $157.15 million, reached on December 31, 2020.
Performance
SPRB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$60.05 M
-$9.63 M-13.82%
September 30, 2024
Summary
- As of February 12, 2025, SPRB quarterly cash and cash equivalents is $60.05 million, with the most recent change of -$9.63 million (-13.82%) on September 30, 2024.
- Over the past year, SPRB quarterly cash and cash equivalents has dropped by -$36.28 million (-37.66%).
- SPRB quarterly cash and cash equivalents is now -61.78% below its all-time high of $157.15 million, reached on December 31, 2020.
Performance
SPRB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SPRB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +293.4% | -37.7% |
| 3 y3 years | -38.7% | -37.7% |
| 5 y5 years | +2242.9% | -37.7% |
SPRB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +293.4% | -39.2% | +177.4% |
| 5 y | 5-year | -38.7% | +2355.1% | -61.8% | +1430.5% |
| alltime | all time | -38.7% | +2355.1% | -61.8% | +1430.5% |
Spruce Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $60.05 M(-13.8%) |
| Jun 2024 | - | $69.68 M(-14.1%) |
| Mar 2024 | - | $81.15 M(-15.8%) |
| Dec 2023 | $96.34 M(+293.4%) | $96.34 M(-2.5%) |
| Sep 2023 | - | $98.80 M(+1.4%) |
| Jun 2023 | - | $97.48 M(+31.9%) |
| Mar 2023 | - | $73.93 M(+201.9%) |
| Dec 2022 | $24.49 M | $24.49 M(+13.1%) |
| Sep 2022 | - | $21.65 M(-54.1%) |
| Jun 2022 | - | $47.21 M(+102.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $23.34 M(-45.4%) |
| Dec 2021 | $42.75 M(-72.8%) | $42.75 M(-26.8%) |
| Sep 2021 | - | $58.36 M(-25.4%) |
| Jun 2021 | - | $78.28 M(-47.3%) |
| Mar 2021 | - | $148.63 M(-5.4%) |
| Dec 2020 | $157.15 M(+3904.8%) | $157.15 M(+117.8%) |
| Sep 2020 | - | $72.16 M(+97.1%) |
| Jun 2020 | - | $36.60 M(+832.7%) |
| Dec 2019 | $3.92 M(-4.6%) | $3.92 M |
| Dec 2018 | $4.11 M | - |
FAQ
- What is Spruce Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Spruce Biosciences?
- What is Spruce Biosciences annual cash & cash equivalents year-on-year change?
- What is Spruce Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Spruce Biosciences?
- What is Spruce Biosciences quarterly cash and cash equivalents year-on-year change?
What is Spruce Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of SPRB is $96.34 M
What is the all time high annual cash & cash equivalents for Spruce Biosciences?
Spruce Biosciences all-time high annual cash & cash equivalents is $157.15 M
What is Spruce Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, SPRB annual cash & cash equivalents has changed by +$71.85 M (+293.43%)
What is Spruce Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SPRB is $60.05 M
What is the all time high quarterly cash and cash equivalents for Spruce Biosciences?
Spruce Biosciences all-time high quarterly cash and cash equivalents is $157.15 M
What is Spruce Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, SPRB quarterly cash and cash equivalents has changed by -$36.28 M (-37.66%)